Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Amgen wins suit against Roche

A jury ruled that Mircera methoxy polyethylene glycol-epoetin beta from Roche (SWX:ROG) infringes

Read the full 135 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE